Terms: = Bone cancer AND SND1, Q7KZF4, TDRD11, p100, ENSG00000197157, 27044 AND Treatment
4 results:
1. [Effect of Staphylococcal Nuclease and Tudor Domain Containing 1/SLC7A11 on the Occurrence and Development of Osteosarcoma by Inhibiting Ferroptosis].
Wang ST; Xu SJ; Gui P; Li XN; Sui YH; Li ZX
Zhongguo Yi Xue Ke Xue Yuan Xue Bao; 2024 Feb; 46(1):11-18. PubMed ID: 38433625
[TBL] [Abstract] [Full Text] [Related]
2. Activity of TAS4464, a novel NEDD8 activating enzyme E1 inhibitor, against multiple myeloma via inactivation of nuclear factor κB pathways.
Muraoka H; Yoshimura C; Kawabata R; Tsuji S; Hashimoto A; Ochiiwa H; Nakagawa F; Fujioka Y; Matsuo K; Ohkubo S
Cancer Sci; 2019 Dec; 110(12):3802-3810. PubMed ID: 31583781
[TBL] [Abstract] [Full Text] [Related]
3. [NF-κB signaling pathways and the future perspectives of bone disease therapy using selective inhibitors of NF-κB].
Jimi E; Fukushima H
Clin Calcium; 2016 Feb; 26(2):298-304. PubMed ID: 26813510
[TBL] [Abstract] [Full Text] [Related]
4. A dominant-negative F-box deleted mutant of E3 ubiquitin ligase, β-TrCP1/FWD1, markedly reduces myeloma cell growth and survival in mice.
Sharma R; Williams PJ; Gupta A; McCluskey B; Bhaskaran S; Muñoz S; Oyajobi BO
Oncotarget; 2015 Aug; 6(25):21589-602. PubMed ID: 26009993
[TBL] [Abstract] [Full Text] [Related]